Pharma companies will succeed or fail based not on how much drug they sell, but on how well their [...]
Read More →The US Risk Evaluation and Mitigation Strategies (REMS) requirements for a drug or drug class are continuously evolving. The [...]
Read More →
IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.
Journal for Clinical Studies (JCS) is a peer reviewed journal which details practical and theoretical operational procedures, challenges, validatory and regulatory guidelines when conducting trials on a multisite basis and particularly within emerging markets, naïve patient population and remote access areas. JCS provides country by country objectives and uniquely brings you experiences in therapeutic areas prevalent in emerging market areas.
